First human test of potential infertility drug completed
NCT ID NCT07264192
Summary
This was the first study in people to check the safety of a potential new medication called HS-10518. It involved 60 healthy premenopausal women in China who took either the drug or a placebo for 14 days. The main goal was to see how safe the drug was and how the body processed it, not to treat any condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFERTILITY, FEMALE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
West China Second University Hospital
Chengdu, China
Conditions
Explore the condition pages connected to this study.